Abbott Laboratories (ABT) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96% |
| Dec 31, 2025 | -3.67% |
| Sep 30, 2025 | -10.42% |
| Jun 30, 2025 | -7.82% |
| Mar 31, 2025 | -13.76% |
| Dec 31, 2024 | -14.50% |
| Sep 30, 2024 | -12.82% |
| Jun 30, 2024 | -17.11% |
| Mar 31, 2024 | -15.99% |
| Dec 31, 2023 | -7.01% |
| Sep 30, 2023 | 1.46% |
| Jun 30, 2023 | -20.91% |
| Mar 31, 2023 | -19.38% |
| Dec 31, 2022 | 1.06% |
| Sep 30, 2022 | 2.51% |
| Jun 30, 2022 | 1.24% |
| Mar 31, 2022 | 1.78% |
| Dec 31, 2021 | 14.31% |
| Sep 30, 2021 | -16.65% |
| Jun 30, 2021 | -15.08% |
| Mar 31, 2021 | -16.25% |
| Dec 31, 2020 | -2.89% |
| Sep 30, 2020 | 5.60% |
| Jun 30, 2020 | 15.31% |
| Mar 31, 2020 | 18.69% |
| Dec 31, 2019 | 2.01% |
| Sep 30, 2019 | 2.83% |
| Jun 30, 2019 | 14.57% |
| Mar 31, 2019 | 15.14% |
| Dec 31, 2018 | 8.88% |
| Sep 30, 2018 | 2.88% |
| Jun 30, 2018 | 19.90% |
| Mar 31, 2018 | 14.54% |
| Dec 31, 2017 | 7.00% |
| Sep 30, 2017 | 0.71% |
| Jun 30, 2017 | 2.44% |
| Mar 31, 2017 | 1.67% |
| Dec 31, 2016 | -22.05% |
| Sep 30, 2016 | 11.08% |
| Jun 30, 2016 | 13.28% |
| Mar 31, 2016 | 3.24% |
| Dec 31, 2015 | -2.04% |
| Sep 30, 2015 | -9.85% |
| Jun 30, 2015 | -20.85% |
| Mar 31, 2015 | -39.09% |
| Dec 31, 2014 | 15.16% |
| Sep 30, 2014 | 11.23% |
| Jun 30, 2014 | -0.33% |